Core Laboratories Inc. (NYSE:CLB) Shares Bought by Millennium Management LLC

Millennium Management LLC boosted its stake in shares of Core Laboratories Inc. (NYSE:CLB - Free Report) by 429.0% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 65,616 shares of the oil and gas company's stock after acquiring an additional 53,213 shares during the period. Millennium Management LLC owned about 0.14% of Core Laboratories worth $1,136,000 at the end of the most recent quarter.

A number of other large investors also recently added to or reduced their stakes in the stock. T. Rowe Price Investment Management Inc. increased its stake in shares of Core Laboratories by 4.2% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 1,158,702 shares of the oil and gas company's stock worth $20,058,000 after purchasing an additional 46,941 shares in the last quarter. Geode Capital Management LLC lifted its stake in Core Laboratories by 0.5% in the 4th quarter. Geode Capital Management LLC now owns 1,058,620 shares of the oil and gas company's stock valued at $18,329,000 after buying an additional 5,416 shares in the last quarter. Dimensional Fund Advisors LP boosted its holdings in Core Laboratories by 3.5% in the 4th quarter. Dimensional Fund Advisors LP now owns 847,983 shares of the oil and gas company's stock worth $14,678,000 after buying an additional 28,393 shares during the last quarter. Northern Trust Corp increased its stake in Core Laboratories by 15.6% during the 4th quarter. Northern Trust Corp now owns 577,752 shares of the oil and gas company's stock worth $10,001,000 after buying an additional 78,173 shares in the last quarter. Finally, Fred Alger Management LLC increased its stake in Core Laboratories by 3.8% during the 4th quarter. Fred Alger Management LLC now owns 556,509 shares of the oil and gas company's stock worth $9,633,000 after buying an additional 20,596 shares in the last quarter. 97.81% of the stock is currently owned by institutional investors and hedge funds.

Core Laboratories Trading Up 1.8%

Core Laboratories stock traded up $0.20 during trading on Friday, reaching $11.17. 225,564 shares of the company were exchanged, compared to its average volume of 403,683. The stock's 50 day simple moving average is $11.83 and its two-hundred day simple moving average is $15.61. The company has a market capitalization of $523.59 million, a P/E ratio of 16.92, a PEG ratio of 0.99 and a beta of 1.40. The company has a debt-to-equity ratio of 0.49, a current ratio of 2.32 and a quick ratio of 1.71. Core Laboratories Inc. has a 52-week low of $10.14 and a 52-week high of $25.13.

Core Laboratories (NYSE:CLB - Get Free Report) last posted its quarterly earnings results on Wednesday, April 23rd. The oil and gas company reported $0.14 EPS for the quarter, missing the consensus estimate of $0.15 by ($0.01). The company had revenue of $123.59 million for the quarter, compared to analysts' expectations of $125.09 million. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. The firm's revenue was down 4.7% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.19 EPS. On average, equities research analysts expect that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Tuesday, May 27th. Shareholders of record on Monday, May 5th were issued a $0.01 dividend. The ex-dividend date was Monday, May 5th. This represents a $0.04 annualized dividend and a yield of 0.36%. Core Laboratories's payout ratio is 6.78%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the company. Stifel Nicolaus decreased their target price on Core Laboratories from $19.00 to $15.00 and set a "hold" rating on the stock in a research report on Tuesday, April 15th. Citigroup reduced their price objective on Core Laboratories from $16.00 to $13.00 and set a "neutral" rating for the company in a research note on Tuesday, May 13th. Finally, Wall Street Zen cut shares of Core Laboratories from a "hold" rating to a "sell" rating in a research note on Friday, April 25th. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. According to MarketBeat, the company currently has an average rating of "Hold" and a consensus target price of $15.00.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.